J3110 Teriparatide injection
J-Codes
Also known as: teriparatide, Forteo, parathyroid hormone analog
Teriparatide (Forteo) injection is a recombinant human parathyroid hormone analog used for osteoporosis treatment in men and postmenopausal women at high fracture risk.
Clinical Context
Indicated for osteoporosis with high fracture risk. Stimulates new bone formation through parathyroid hormone receptor signaling. Administered subcutaneously daily for up to 2 years. Often used after bisphosphonate therapy.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.